240 related articles for article (PubMed ID: 31660078)
21. Simultaneous monitoring of the drug release and antitumor effect of a novel drug delivery system-MWCNTs/DOX/TC.
Dong X; Sun Z; Wang X; Zhu D; Liu L; Leng X
Drug Deliv; 2017 Nov; 24(1):143-151. PubMed ID: 28156171
[TBL] [Abstract][Full Text] [Related]
22. Dendronized nanoconjugates of lysine and folate for treatment of cancer.
Jain K; Gupta U; Jain NK
Eur J Pharm Biopharm; 2014 Aug; 87(3):500-9. PubMed ID: 24698808
[TBL] [Abstract][Full Text] [Related]
23. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
[TBL] [Abstract][Full Text] [Related]
24. Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer.
Fu J; Wang D; Mei D; Zhang H; Wang Z; He B; Dai W; Zhang H; Wang X; Zhang Q
J Control Release; 2015 Apr; 204():11-9. PubMed ID: 25646783
[TBL] [Abstract][Full Text] [Related]
25. A pH-responsive Pickering Nanoemulsion for specified spatial delivery of Immune Checkpoint Inhibitor and Chemotherapy agent to Tumors.
Jia L; Pang M; Fan M; Tan X; Wang Y; Huang M; Liu Y; Wang Q; Zhu Y; Yang X
Theranostics; 2020; 10(22):9956-9969. PubMed ID: 32929327
[No Abstract] [Full Text] [Related]
26. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
28. Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance.
Chen X; Cvetkovic D; Ma CM; Chen L
Med Phys; 2012 May; 39(5):2780-6. PubMed ID: 22559650
[TBL] [Abstract][Full Text] [Related]
29. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.
Ramasamy T; Poudel BK; Ruttala H; Choi JY; Hieu TD; Umadevi K; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Oct; 146():152-60. PubMed ID: 27318960
[TBL] [Abstract][Full Text] [Related]
30. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
31. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
32. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment.
Kim MG; Shon Y; Kim J; Oh YK
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27615014
[TBL] [Abstract][Full Text] [Related]
33. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
34.
Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
[No Abstract] [Full Text] [Related]
35. Doxorubicin conjugated functionalizable carbon dots for nucleus targeted delivery and enhanced therapeutic efficacy.
Yang L; Wang Z; Wang J; Jiang W; Jiang X; Bai Z; He Y; Jiang J; Wang D; Yang L
Nanoscale; 2016 Mar; 8(12):6801-9. PubMed ID: 26957191
[TBL] [Abstract][Full Text] [Related]
36. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
37. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
[TBL] [Abstract][Full Text] [Related]
38. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
40. Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy?
Al-Hallak KM; Azarmi S; Anwar-Mohamed A; Roa WH; Löbenberg R
Eur J Pharm Biopharm; 2010 Sep; 76(1):112-9. PubMed ID: 20452423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]